• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Repeated medial branch blocks do not improve pain outcomes for thermal radiofrequency ablation

byPaary BalakumarandAlex Chan
June 21, 2025
in Cardiology, Neurology, Pediatrics Classics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. For patients with facet-mediated spine pain that achieve ≥80% pain relief after a medial branch block, a second diagnostic block does not improve post-radiofrequency ablation pain outcomes but may delay definitive treatment.

Evidence Rating Level: 2 (Good) 

This retrospective study examined whether receiving one versus two medial branch blocks (MBBs) prior to thermal radiofrequency ablation (tRFA) influenced pain outcomes in patients with facet-mediated spine pain. Existing guidelines often recommend dual MBBs before tRFA, though their necessity remains controversial. At a single academic center, 645 tRFA procedures performed between 2017 and 2021 were screened, yielding 312 cases with adequate follow-up data: 161 underwent one MBB and 151 received two. All patients had ≥80% pain relief after MBB, the center’s threshold for a positive diagnostic block. Pain outcomes at 3 months post-tRFA were assessed and compared using t-tests and χ² analyses. The average reported pain relief was 69.5%, with 85.3% of patients reporting ≥50% relief and 58.3% reporting ≥80% relief—no significant differences emerged between the one- and two-block groups. However, the time from the first MBB to tRFA was significantly longer in the two-block group (95.3 vs. 44.2 days, p<0.001). These findings align with prior research suggesting minimal added value of a second diagnostic block in predicting tRFA success and support recent guideline revisions discouraging routine use of dual MBBs. Limitations include the retrospective design, exclusion of many cases due to incomplete data, and reliance on self-reported pain outcomes.

Click to read the study in RAPM

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Sodium-glucose cotransporter 2 inhibitors may improve left ventricular diastolic function in hypertrophic cardiomyopathy

2 Minute Medicine Rewind February 16, 2026

The Scan by 2 Minute Medicine®: Oral GLP 1 reshapes obesity visits, deepfake doctors fuel DIY injectables, home longevity scales overwhelm clinics, and TV CPR scripts leave bystanders unprepared

Tags: anesthesiacardiologynerve blockpain medicine
Previous Post

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

Next Post

Reductions in pain catastrophizing are associated with improvements in emotional functioning

RelatedReports

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Sodium-glucose cotransporter 2 inhibitors may improve left ventricular diastolic function in hypertrophic cardiomyopathy

February 17, 2026
Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma
Weekly Rewinds

2 Minute Medicine Rewind February 16, 2026

February 16, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: Oral GLP 1 reshapes obesity visits, deepfake doctors fuel DIY injectables, home longevity scales overwhelm clinics, and TV CPR scripts leave bystanders unprepared

January 26, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026
Next Post
Parental nonmedical prescription opioid use linked to adolescent use

Reductions in pain catastrophizing are associated with improvements in emotional functioning

2 Minute Medicine Rewind June 23, 2025

Patient Basics: Lung Cancer Overview

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Safety and efficacy profile of first-in-class oral p53 reactivator rezatapopt
  • Ex vivo gene therapy for cystinosis had acceptable safety and improved disease biomarkers
  • Replacing sedentary time with physical activity may lower risk of all-cause mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.